Merck & Co., Inc. company information, Employees & Contact Information

The new manufacturing facilities powering our US growth Merck.com

Infectious disease detection and prevention Merck.com

Our Q2 2025 financial results Merck.com

When cancer comes back Merck.com

Meet two scientists at the forefront of our HIV research Merck.com

Addressing the global shortage of TICE BCG Merck.com

Exploring KRAS: A precision approach in oncology Merck.com

Investor Event at ASCO 2025 Merck.com

Ophthalmology Merck.com

Macrocyclic peptides: a new research frontier Merck.com

Inspiring innovation through diversity and inclusion Merck.com

Data science and artificial intelligence Merck.com

Translational medicine Merck.com

Merck publishes Purpose for Progress Impact Report 2024/2025 Merck.com

Make time to get screened for cancer Merck.com

Our researchers incorporate LLMs to accelerate drug discovery and development Merck.com

Our Q1 2025 financial results Merck.com

How we’re addressing health literacy Merck.com

Our Q4 and full-year 2024 financial results Merck.com

The latest episode of the Merck saga Wolters Kluwer

Merck to Hold Third-Quarter 2025 Sales and Earnings Conference Call Oct. 30 Business Wire

Merck Manuals Shares What Patients Need to Know About COPD PR Newswire

Merck Announces Fourth-Quarter 2025 Dividend Yahoo Finance

Merck to Hold Investor Event to Highlight Advancing Research Pipeline for HIV Treatment and Prevention Yahoo Finance

Merck Breaks Ground on $3 Billion Center of Excellence for Pharmaceutical Manufacturing in Elkton, Virginia FinancialContent

Merck To Acquire Verona Pharma and Expand its COPD Treatment Pipeline Pharmaceutical Executive

Merck Unveils New Facility to Increase Vaccine Production Capacity Yahoo Finance

Merck Announces First-Quarter 2025 Financial Results Business Wire

Sustainability Merck.com

Merck (MRK) Stock Could Skyrocket: Key Drug Approvals & Analyst Targets Unveiled ts2.tech

UK court dismisses appeal in Merck v Merck dispute The Global Legal Post

Merck publishes 2023/2024 Impact Report Merck.com

Business development and licensing (BD&L) Merck.com

Merck Announces Second-Quarter 2025 Dividend and $10 Billion Share Repurchase Authorization Yahoo Finance

Merck's Game-Changing Single-Dose Dengue Vaccine Enters Final Testing Phase - What Sets It Apart Stock Titan

FDA Approves Merck’s WINREVAIR™ (sotatercept-csrk), a First-in-Class Treatment for Adults with Pulmonary Arterial Hypertension (PAH, WHO* Group 1) Merck.com

Individualized neoantigen therapies: exploring one medicine for one patient Merck.com

European Commission (EC) Approves Merck’s CAPVAXIVE® (Pneumococcal 21-valent Conjugate Vaccine) for Prevention of Invasive Pneumococcal Disease and Pneumococcal Pneumonia in Adults Business Wire

Our Pipeline at a glance Merck.com

Neuroscience discovery and development Merck.com

Code of conduct, ethics & compliance Merck.com

A new foundation for future talent Merck.com

Merck’s Clesrovimab (MK-1654), an Investigational Respiratory Syncytial Virus (RSV) Preventative Monoclonal Antibody, Significantly Reduced Incidence of RSV Disease and Hospitalization in Healthy Preterm and Full-term Infants Merck.com

How Merck scientists are driving next-generation cancer research Merck.com

Staying positive with pulmonary arterial hypertension Merck.com

What we do Merck.com

Drug discovery and development Merck.com

Driving prostate cancer research forward Merck.com

Prostate cancer: stigma, early screening and support Merck.com

Diversity and inclusion Merck.com

Who we are Merck.com

Merck Announces First-Quarter 2025 Dividend Yahoo Finance

35 Years: The Mectizan® Donation Program Merck.com

What is One Pipeline? Merck.com

VIDEO: Living with pulmonary arterial hypertension Merck.com

Transparency disclosures Merck.com

Merck Unveils New Facility to Increase Vaccine Production Capacity FinancialContent

Biomarker testing may help inform treatment decisions in certain cancers Merck.com

Our history Merck.com

Surendralal Karsanbhai Elected to Merck Board of Directors Yahoo Finance

Vaccines Merck.com

Teaming up with Eisai to help fight cancer Merck.com

Here for Good: A steadfast commitment to global health Merck.com

Play an active role in your health care Merck.com

Supporting colleagues working with cancer Merck.com

Heart failure: A physician’s perspective Merck.com

Our culture and values Merck.com

Patients Merck.com

Harnessing innovative technology in drug discovery Merck.com

Our COVID-19 efforts Merck.com

Merck for Mothers: Expanding access to quality maternal care Merck.com

How employees with careers in nursing are critical at Merck Merck.com

Why you shouldn’t postpone cancer screenings Merck.com

Measles: signs and symptoms Merck.com

Podcast: Meet the dealmakers Merck.com

Vaccines: Our history, our legacy Merck.com

Merck Animal Health hiring for various positions The Employment Journey

How ChatGPT & Co. Will Change Our Work: Four Hypotheses About Working with (Generative) Artificial Intelligence Merck Group

Merck Named One of Fortune’s 2023 100 Best Companies to Work For(R) Yahoo Finance

Daiichi Sankyo and Merck Announce Global Development and Commercialization Collaboration for Three Daiichi Sankyo DXd ADCs Business Wire

Merck to acquire EyeBio for upfront payment of $1.3 billion Ophthalmology Times

Merck Animal Health Completes Acquisition of Elanco’s Aqua Business Yahoo Finance

Merck to Acquire Harpoon Therapeutics, Further Diversifying Oncology Pipeline Business Wire

Daiichi Sankyo and Merck Enter into Global Development and Commercialization Agreement for MK-6070 Business Wire

In another round of Merck vs. Merck, Germany-based Merck KGaA notches a win in the U.K. Fierce Pharma

Merck (MRK): Company Profile, Stock Price, News, Rankings Fortune

Patritumab Deruxtecan Demonstrated Statistically Significant Improvement in Progression-Free Survival Versus Doublet Chemotherapy in Patients with Locally Advanced or Metastatic EGFR-Mutated Non-Small Cell Lung Cancer in HERTHENA-Lung02 Phase Business Wire

Merck to Acquire VelosBio Business Wire

Merck's HIV Campaign, I Design, Partners with Music Industry Promoter and HIV Advocate Maria Davis and Positive Women's Network - USA to Encourage Women Living with HIV to be "Vocal" about their Treatment Fierce Pharma

Lilly and Merck Expand Immuno-Oncology Collaboration Adding Abemaciclib and KEYTRUDA® Combination Trial PR Newswire

Allergan Enters Into Licensing Agreement with Merck to Obtain Exclusive Worldwide Rights to CGRP Migraine Development Program PR Newswire

Tim McGraw, Merck and the American Diabetes Association Challenge Americans with Type 2 Diabetes to Get to Their A1C Goal Fierce Pharma

Award-Winning Actress S. Epatha Merkerson and Merck Challenge African Americans with Type 2 Diabetes to Get to Their Goals PR Newswire

Merck & Co Inc (MRK) Stock Price, Trades & News GuruFocus

Merck & Co., Inc. (MRK) Stock Price, News & Analysis MarketBeat

[node:Title] CSRwire

Merck Company Foundation Expands Network of Immunization Training Centers in Africa CSRwire